Andres Finzi of the Centre Hospitalier de l'Université de Montréal in Canada will develop a system called "reverse fusion" in which viral-like particles that incorporate the HIV receptor CD4 and its co-receptors CCR5 and CXCR4 fuse specifically with HIV-infected cells to deliver toxic genes that kill the HIV-infected cells.
Grant ID
OPP1042670
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False